Bio

Ben Clarke supports USP’s portfolio of documentary and physical reference standards for the Global Biologics group. He specializes in cell and gene therapy, vaccines and monoclonal antibodies. Before joining USP, Ben developed analytical bioassays at GSK Vaccines for RSV and self-amplifying mRNA vaccines. Before GSK Vaccines, he pioneered the development of mouse models of sphingolipid biology using CRISPR/Cas9 genome editing technology at the National Institute for Health. Before NIH, we optimized upstream PER.C6 cell culture for the production of Adenovirus at Janssen. He received his Ph.D. from Cornell University in 2012 for his work on mammalian membrane biology and lipid remodeling enzymes. He received his B.S. from Pennsylvania State University for Biochemistry, Molecular, and Cell Biology.